• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan+
  • Wellness
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Career
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan+
  • Wellness
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Career
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home StudyGraphics

#VisualAbstract: Higher Nicotine Consumption Observed Among Youth with Attention-Deficit-Hyperactivity Disorder

byAngel GaoandAlisha Yi
April 16, 2025
in StudyGraphics
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. This cohort of United States youths with asymptomatic attention-deficit hyperactivity disorder (ADHD), did not have statistically significant differences in their odds of starting nicotine or tobacco products compared with the control group. 

2. The youths with more ADHD symptoms had a greater likelihood of starting nicotine or tobacco products compared to the control group.

Evidence Rating Level: 2 (Good)

Study Rundown: Tobacco use is the leading cause of preventable death worldwide. The relationship between tobacco and attention-deficit/hyperactivity disorder (ADHD) has been well established although changing over time. Features of ADHD include functional impairment, lack of attention, and possibly hyperactivity. This cohort study aimed to find additional research regarding the association between tobacco use and ADHD. Included in the cohort were children aged 12 to 17 years old along with their parents, from baseline in September 2013 to April 2023. The key outcome of interest was the new onset of 4 nicotine or tobacco use among youths who reported no lifetime use at baseline. The parent participants reported if their child had been diagnosed with ADHD or ADD, and if so, were they taking regular medication. The youth completed questions from the Global Appraisal of Individual Needs (GAIN) assessment including a list of symptoms listed on the PhenX Toolkit. When compared to the control group, individuals with asymptomatic ADHD did not significantly differ in the likelihood of initiating cigarette use, dual use, or other tobacco use throughout the study period. On the other hand, youth with symptomatic ADHD had a greater chance of starting nicotine or tobacco products during the study period. This study included individuals 12 years of age and older, however, some youths had already initiated nicotine or tobacco by this age. Future research should aim to evaluate ADHD symptoms corresponding with nicotine and tobacco use earlier. Overall, the study findings highlight the importance of early ADHD diagnosis and treatment in youths to prevent future nicotine and tobacco use.

Click here to read the study in JAMA Network Open

RELATED REPORTS

2 Minute Medicine Rewind May 12, 2025

Maternal hypertension associated with adverse neurodevelopment outcomes in preterm infants

Critical-care pain observation tool demonstrates reliability for critically ill pediatric patients

Tags: ADHDAttention-defitinicotinepediatricstobaccotobacco useUsevapingYouths
Previous Post

#VisualAbstract: Pulsed Field Ablation is Noninferior to Cryoballoon Ablation for Paroxysmal Atrial Fibrillation

Next Post

Sotorasib plus panitumumab may be a promising treatment option for colorectal cancer

RelatedReports

Biosimilar to infliximab shows equivalent safety and efficacy for treating Crohn’s disease
Weekly Rewinds

2 Minute Medicine Rewind May 12, 2025

May 14, 2025
Prevalence of hypertension among adolescents varies by race and BMI
Chronic Disease

Maternal hypertension associated with adverse neurodevelopment outcomes in preterm infants

May 10, 2025
Neonatal neuroimaging with strong negative predictive value for developmental outcomes: The NEURO study
Emergency

Critical-care pain observation tool demonstrates reliability for critically ill pediatric patients

April 26, 2025
Pediatric palliative care outcome measures often miss quality of life
Emergency

Epinephrine inferior to norepinephrine as initial treatment in children with septic shock

April 20, 2025
Next Post
Benefits of high-intensity surveillance following colorectal adenoma removal likely outweigh costs

Sotorasib plus panitumumab may be a promising treatment option for colorectal cancer

#VisualAbstract: Sotatercept Improves Outcomes in Patients with Pulmonary Arterial Hypertension at High Risk for Death

#VisualAbstract: Sotatercept Improves Outcomes in Patients with Pulmonary Arterial Hypertension at High Risk for Death

Elective colectomy associated with improved survival in ulcerative colitis

Inflammatory bowel disease may be associated with increased risk of osteoporosis and osteopeia

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • FDA Approves Dupilumab for Chronic Spontaneous Urticaria
  • Mental Health Chatbot Woebot Shown to Help with Postpartum Depression and Anxiety
  • AI Symptom-Checker Could Help Emergency Doctors Prioritize Patients
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Career
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.